Destination Wealth Management’s Biogen BIIB Stock Holding History

Destination Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-287	Closed	-$67K	–	181
2019 Q2	$67K	Sell	287 -3	-1%	-$693	﹤0.01%	234
2019 Q1	$69K	Buy	290 +3	+1%	+$945	﹤0.01%	227
2018 Q4	$86K	Sell	287 -4	-1%	-$1.28K	0.01%	194
2018 Q3	$103K	Buy	291 +4	+1%	+$1.38K	0.01%	199
2018 Q2	$83K	Hold	287	–	–	0.01%	206
2018 Q1	$79K	Buy	+287	New	+$89.1K	﹤0.01%	209

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Destination Wealth Management's BIIB Position: Q3 2019 in Review

Destination Wealth Management sold out of Biogen (BIIB) in Q3 2019, closing a stake of 287 shares — an estimated $67K sold.

Destination Wealth Management first reported a position in BIIB in Q1 2018 and held it in 6 quarters. The position peaked at $103K in Q3 2018. 988 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

Destination Wealth Management reported no remaining Biogen position as of Q3 2019 after selling out during the quarter.
Destination Wealth Management sold 287 Biogen shares in Q3 2019, an estimated $67K.
Destination Wealth Management first reported a position in Biogen in Q1 2018 and held it in 6 quarters.
Destination Wealth Management's Biogen position peaked at $103K in Q3 2018.
988 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on Destination Wealth Management's 13F filing for Q3 2019, filed 13 Nov 2019.